1. Home
  2. PLBY vs LEXX Comparison

PLBY vs LEXX Comparison

Compare PLBY & LEXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLBY
  • LEXX
  • Stock Information
  • Founded
  • PLBY 1953
  • LEXX 2004
  • Country
  • PLBY United States
  • LEXX Canada
  • Employees
  • PLBY N/A
  • LEXX N/A
  • Industry
  • PLBY Recreational Games/Products/Toys
  • LEXX Biotechnology: Pharmaceutical Preparations
  • Sector
  • PLBY Consumer Discretionary
  • LEXX Health Care
  • Exchange
  • PLBY Nasdaq
  • LEXX Nasdaq
  • Market Cap
  • PLBY 53.2M
  • LEXX 49.3M
  • IPO Year
  • PLBY N/A
  • LEXX N/A
  • Fundamental
  • Price
  • PLBY $0.72
  • LEXX $3.06
  • Analyst Decision
  • PLBY Buy
  • LEXX Strong Buy
  • Analyst Count
  • PLBY 2
  • LEXX 2
  • Target Price
  • PLBY $2.35
  • LEXX $11.00
  • AVG Volume (30 Days)
  • PLBY 206.8K
  • LEXX 92.3K
  • Earning Date
  • PLBY 11-07-2024
  • LEXX 11-18-2024
  • Dividend Yield
  • PLBY N/A
  • LEXX N/A
  • EPS Growth
  • PLBY N/A
  • LEXX N/A
  • EPS
  • PLBY N/A
  • LEXX N/A
  • Revenue
  • PLBY $125,850,000.00
  • LEXX $411,019.00
  • Revenue This Year
  • PLBY N/A
  • LEXX $82.02
  • Revenue Next Year
  • PLBY N/A
  • LEXX $95.09
  • P/E Ratio
  • PLBY N/A
  • LEXX N/A
  • Revenue Growth
  • PLBY N/A
  • LEXX 34.05
  • 52 Week Low
  • PLBY $0.43
  • LEXX $0.90
  • 52 Week High
  • PLBY $1.55
  • LEXX $6.85
  • Technical
  • Relative Strength Index (RSI)
  • PLBY 51.89
  • LEXX 45.40
  • Support Level
  • PLBY $0.66
  • LEXX $2.92
  • Resistance Level
  • PLBY $0.76
  • LEXX $3.39
  • Average True Range (ATR)
  • PLBY 0.05
  • LEXX 0.19
  • MACD
  • PLBY -0.00
  • LEXX -0.01
  • Stochastic Oscillator
  • PLBY 45.83
  • LEXX 31.12

About PLBY PLBY Group Inc.

PLBY Group Inc connects consumers around the world with products, services, and experiences to help them look good, feel good, and have fun. PLBY Group serves consumers in four categories: Style and Apparel, Digital Entertainment and Lifestyle, Sexual Wellness, and Beauty and Grooming. It operates through three segments Direct-to-Consumer, Licensing, and Digital Subscriptions and Content. It generates revenue through the sales of products and content services to consumers.

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH has the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. The Company has four reportable segments: Intellectual Property Licensing, B2B Production, Research and Development and Corporate. It earns maximum revenue from Intellectual Property Licensing.

Share on Social Networks: